HT structure determination of GPCRs by LCP serial femtosecond nanocrystallography
LCP 系列飞秒纳米晶体学测定 GPCR 的 HT 结构
基本信息
- 批准号:8612932
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-15 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressArizonaBehaviorCathepsins BCellsCollaborationsComplexDataData CollectionData SetDepositionDetergentsDevelopmentDigestionDrug TargetingElectronsEnvironmentFamilyFreezingFundingG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGelGenerationsGoalsHIVHarvestHumanHuman GenomeImmuneLaboratoriesLasersLeadLigandsMalignant NeoplasmsMembraneMembrane ProteinsMethodsMuramidasePathway interactionsPhasePhotosystem IPhysiologic pulsePhysiologicalPoriferaProcessProductionProteinsProtocols documentationPsyche structureRadiationReactionReproductionResearchResolutionRoentgen RaysRunningSamplingScientistSignal TransductionSolidSolutionsSolventsSourceStreamStructureSuby&aposs G solutionSupport SystemSynchrotronsTechnologyTestingTherapeuticTimeUniversitiesValidationVisionbasebeamlinecomputerized data processingdensitydrug discoverydrug marketextracellularimprovedmembermimeticsnovelpathogenprogramspublic health relevancereceptorresponsesilicon nitridesoftware developmentsuccessthree dimensional structure
项目摘要
This project aims to develop protocols that will lead to the establishment of a robust high-throughput pipeline
for the atomic-level structural characterization of membrane protein microcrystals grown in membrane-like
environment of lipidic cubic phase (LCP) using serial femtosecond nanocrystallography (SFX) at free electron
X-ray laser sources (XFELs). With the use of SFX, we will obviate the need for obtaining large crystals,
effectively eliminate radiation damage issues through "diffraction before destruction" (i.e., diffraction data are
collected prior to onset of any damage), simplify handling, as harvesting and freezing are not required, and
significantly reduce the time from obtaining initial crystal hits to collecting full data sets. Our long term goal is
the integration of this technology into our structural determination pipeline enabling the determination of a large
number of three-dimensional structures of G protein-coupled receptors (GPCRs)-ligand complexes addressing
questions on ligand selectivity and efficacy using structure-based drug discovery (SBDD) approaches. Our
goal will be achieved through the following specific aims. Aim 1: Develop protocols for the production of
samples of GPCR-ligand complexes and for the generation, and characterization of large number of
microcrystals that can be used for SFX studies. Aim 2: Develop protocols for SFX data collection, processing
and structure solution of GPCR-ligand complexes. Aim 3: Integrate protocols developed in Aims 1 and 2 into
the GPCR Structure Determination Pipeline and optimize and validate the modified pipeline by determining the
structure of novel GPCRs including a number of receptor-ligand complexes. GPCRs constitute the largest
family of membrane proteins in the human genome with approximately 800 members and are responsible for
transmitting variety of extracellular signals inside the cell, thereby controlling all major physiological responses,
including vision, olfactory, immune defense, reproduction, digestion, mental behavior and others; several
GPCRs are exploited as co-receptors for entry by HIV and other pathogens. GPCR signaling through multiple
effector pathways has profound therapeutic implications, which underscores the need to understand the
receptor both biochemically and structurally in the proper context. GPCRs are the target of ~40% of currently
marketed drugs. However, detailed understanding of their mechanism of action and ligand selectivity is limited
by a lack of structural information. The structure determination of GPCRs is hampered by the difficulty of
preparing large amounts of homogenous and stable samples and growing sufficiently large crystals for high-
resolution structure determination even when using state-of-the art microfocus beamlines at synchrotron
sources.
该项目旨在制定协议,以建立一个强大的高通量管道
用于膜状生长的膜蛋白微晶体的原子水平结构表征
自由电子飞秒纳米微阵列(SFX)技术在立方相(LCP)环境中的应用
X射线激光源(XFEL)。随着SFX的使用,我们将不再需要获得大晶体,
通过“破坏前的衍射”(即,衍射数据
在任何损害发生之前收集),简化处理,因为不需要收获和冷冻,以及
显著减少从获得初始晶体命中到收集完整数据集的时间。我们的长期目标是
将该技术集成到我们的结构测定管道中,
G蛋白偶联受体(GPCR)-配体复合物的三维结构的数量,
使用基于结构的药物发现(SBDD)方法的配体选择性和有效性问题。我们
将通过以下具体目标实现这一目标。目标1:制定生产
GPCR-配体复合物的样品,并用于产生和表征大量的
可用于SFX研究的微晶。目标2:制定SFX数据收集、处理和
以及GPCR-配体复合物的结构解析。目标3:将目标1和2中制定的协议纳入
GPCR结构确定流水线,并通过确定
包括许多受体-配体复合物的新型GPCR的结构。GPCR是最大的
人类基因组中的膜蛋白家族,约有800个成员,负责
在细胞内传递各种细胞外信号,从而控制所有主要的生理反应,
包括视觉、嗅觉、免疫防御、生殖、消化、精神行为等;
GPCR被用作HIV和其他病原体进入的共受体。GPCR信号通过多个
效应通路具有深远的治疗意义,这强调了了解
受体的生物化学和结构在适当的情况下。GPCR是目前约40%的目标
市售药品。然而,对它们的作用机制和配体选择性的详细了解是有限的
缺乏结构性信息。GPCR的结构测定受到以下困难的阻碍:
制备大量均匀和稳定的样品,并生长足够大的晶体,
即使在同步加速器上使用最先进的微聚焦光束线,
源
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vadim Cherezov其他文献
Vadim Cherezov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vadim Cherezov', 18)}}的其他基金
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief
用于缓解神经性疼痛的非成瘾性血管紧张素 AT2 抑制剂
- 批准号:
10396694 - 财政年份:2020
- 资助金额:
$ 5万 - 项目类别:
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief
用于缓解神经性疼痛的非成瘾性血管紧张素 AT2 抑制剂
- 批准号:
10405661 - 财政年份:2020
- 资助金额:
$ 5万 - 项目类别:
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief
用于缓解神经性疼痛的非成瘾性血管紧张素 AT2 抑制剂
- 批准号:
10645104 - 财政年份:2020
- 资助金额:
$ 5万 - 项目类别:
Structure guided design of photoselectable channelrhodopsins
光选择性通道视紫红质的结构引导设计
- 批准号:
9244699 - 财政年份:2016
- 资助金额:
$ 5万 - 项目类别:
Structure guided design of photoselectable channelrhodopsins
光选择性通道视紫红质的结构引导设计
- 批准号:
9360611 - 财政年份:2016
- 资助金额:
$ 5万 - 项目类别:
HT structure determination of GPCRs by LCP serial femtosecond nanocrystallography
LCP 系列飞秒纳米晶体学测定 GPCR 的 HT 结构
- 批准号:
9078982 - 财政年份:2014
- 资助金额:
$ 5万 - 项目类别:
相似海外基金
EA: Upgrading the Geophysics Computing Facility at Arizona State University
EA:升级亚利桑那州立大学的地球物理计算设施
- 批准号:
2348594 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
REU Site: Astronomy and Planetary Science research in Flagstaff, Arizona
REU 站点:亚利桑那州弗拉格斯塔夫的天文学和行星科学研究
- 批准号:
2349774 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Conference: A Quarter Century of Peridynamics (PD25); Tucson, Arizona; 22-25 April 2024
会议:近场动力学的四分之一世纪(PD25);
- 批准号:
2409104 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
EA: Upgrade of the Laser Heating System in the High-Pressure Diamond-Anvil Cell Laboratory at Arizona State University
EA:亚利桑那州立大学高压金刚石砧室实验室激光加热系统升级
- 批准号:
2335071 - 财政年份:2024
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Conference: GRANTED DCL: Arizona Regional Coalition of Leaders in Advanced Research Administration (CLARA)
会议:授予 DCL:亚利桑那州高级研究管理领导者地区联盟 (CLARA)
- 批准号:
2324589 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
SCC-PG: Getting the Edge on Data-Driven Self-Managed Care: A Focus on Older Veterans in Arizona
SCC-PG:在数据驱动的自我管理护理方面取得优势:关注亚利桑那州的老年退伍军人
- 批准号:
2231874 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Collaborative Research: Accessing the dark Arizona skies for research and education, a NCAT-BU partnership
合作研究:进入亚利桑那州黑暗的天空进行研究和教育,NCAT-BU 合作伙伴关系
- 批准号:
2319305 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Standard Grant
Graduate Industrial Hygiene Training Program Grant, University of Arizona
亚利桑那大学研究生工业卫生培训计划补助金
- 批准号:
10730704 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Louis Stokes STEM Pathways Implementation-Only Alliance: Southern Nevada Northern Arizona
Louis Stokes STEM 途径实施联盟:内华达州南部 亚利桑那州北部
- 批准号:
2307200 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Continuing Grant